CLINICAL_TRIALS
trial_result
· 2014-10-08
Clinical Trial Update: 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder [Phase 4]
Summary
Phase 4 study of desvenlafaxine (Pristiq) for social anxiety disorder has completed. Results were posted on October 8, 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The Medical Research Network | Conditions: Social Anxiety Disorder | Phase 4 | Status: COMPLETED | Results posted: 2014-10-08